HIV/HBV/HCV Test Kits Market is Expected to Rise to US$ 11,573.9 Million by 2033, At a CAGR of 5.8% | Future Market Insights, Inc.

NEWARK, DE / ACCESSWIRE / March 21, 2023 / The HIV/HBV/HCV test kits market size is projected to be valued at US$ 6,568.3 million in 2023 and is expected to rise to US$ 11,573.9 million by 2033. The sales of HIV/HBV/HCV test kits are expected to grow at a significant CAGR of 5.8% during the forecast period.

The global incidence of HIV and hepatitis has increased significantly, and this is expected to drive HIV/HBV/HCV test kit consumption. With HIV and hepatitis infections being major public health issues around the world, there is a high demand for effective diagnostic services for these diseases.

• According to the WHO's June 2022 report, an estimated 58 million people worldwide have chronic hepatitis C virus infection, with approximately 1.5 million new cases occurring each year. An estimated 3.2 million adolescents and children are infected with chronic hepatitis C. The disease's high prevalence is expected to drive market growth.

Get a holistic overview of the market from industry experts to evaluate and develop growth strategies. Download the sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-9814

Governments and non-governmental organizations (NGOs) all over the world are taking steps to raise awareness about STD testing and its significance in the fight against HIV and hepatitis.

• This has resulted in a significant increase in global awareness, with initiatives such as 'Start Talking. Stop HIV/AIDS' and "World Hepatitis Day" every year to increase awareness and understanding of these chronic diseases.

Since early diagnosis improves disease treatment, these awareness campaigns are expected to increase demand for HIV/HBV/HCV test kits globally and accelerate market growth.

Rising medical diagnostics research and development, rising HIV and hepatitis incidence, increased awareness among the general population, increasing medical expenditure, technological developments in diagnostics, and other major factors are expected to drive consumption of HIV/HBV/HCV test kits.

Key Takeaways from the HIV/HBV/HCV Test Kits Market

• The North America HIV/HBV/HCV test kits market accounts for a dominant market position in the global marketplace, with a share of 33.4% in 2022, and is expected to maintain this position throughout the forecast period. Rising cases of sexually transmitted infections (STIs) and sexually transmitted diseases (STDs) in the region are responsible for HIV/HBV/HCV test kit sales significantly.
• The blood sample segment is anticipated to witness a strong growth of 6.1% during the 2023-2033 period. The primary reason for the expansion of this segment is the increased number of tests required prior to blood or blood product transfusion. The increasing use of serological tests for blood group typing, as well as mandatory screening tests for HIV, HCV, HBV, syphilis, and malaria, are driving the segment's growth.
• East Asian and South Asian markets for HIV/HBV/HCV testing equipment currently account for 21.9% and 6.2% of the global industry, respectively. Sales of HIV/HBV/HCV test kits in these regions are projected to be fueled by densely populated nations such as India and China as their emphasis on healthcare grows.
• The market's primary part, assay-based test kits, is growing at a 6.4% annual pace. Assay kits are the primary method used for patient testing. Moreover, assay-based testing findings are used by medical professionals and patients in the majority of developing nations.

Expand operations in the future - To get requisite details, ask for a custom report @ https://www.futuremarketinsights.com/customization-available/rep-gb-9814

Manufacturers are constantly evolving business models

Companies in the HIV/HBV/HCV test kits market are moderately competitive by nature, with several major players present. These players are part of several strategic alliances. The agreement and system automation speed up the manufacturer's strategy to capitalize on market share and capture a sizable market share.

Latest Developments

• November 2021 - Siemens Healthineers AG and Hemogenomics funded a clinical trial to compare the ADVIA Centaur XP chemiluminescence system for HIV, HCV, and Syphilis screening in blood donors from India.
• NATSpert, an Individual Donor Nucleic Acid Test (ID-NAT) to screen for HIV, HBV, and HCV in donated blood, was launched in April 2019 by Mylab Discovery Solutions.

HIV/HBV/HCV Test Kits Market by Solution

HIV/HBV/HCV Test Kits Market by Test Kit Type:

• Assay-based Test Kits
• Rapid Test Kits

HIV/HBV/HCV Test Kits Market by Sample:

• Blood
• Urine
• Saliva

HIV/HBV/HCV Test Kits Market by End User:

• HIV/HBV/HCV Test Kits for Hospitals
• HIV/HBV/HCV Test Kits for Clinics
• HIV/HBV/HCV Test Kits for Diagnostic Laboratories
• HIV/HBV/HCV Test Kits for Government Organizations and NGOs
• Others

Full Report @ https://www.futuremarketinsights.com/reports/hiv-hbv-hcv-test-kits-market

Table of Content

1. Executive Summary | HIV/HBV/HCV Test Kits Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2033, Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-9814

Explore FMI's Extensive Coverage On Healthcare Domain:

HIV Antivirals Market Size : The market for HIV antivirals is expected to reach US$ 30.6 billion in 2022 and grow at a CAGR of 4.4% during the same period (2022-2032).

HIV Diagnostics Market Demand : Throughout the years 2022-2032, the HIV diagnostics market is projected to grow at a consistent CAGR of 7.9%. The market for HIV diagnostics is anticipated to grow during the projected period, from US$ 3.0 billion in 2022 to US$ 6.4 billion in 2032.

Prophylactic HIV drugs Market Share : In order to prevent HIV infection and AIDS, the market for prophylactic HIV medications is expected to grow by 4% between 2022 and 2032, reaching approximately US$ 40 billion in 2028.

Infection Prevention Market Opportunity: The infection prevention market is expected to grow at a CAGR of 4% from 2023 to 2033. By 2023, the market will be worth $40.8 billion USD. The market is anticipated to reach an estimated value of $60.6 billion by 2033.

HIV Diagnostics Market Growth : Throughout the years 2022-2032, the HIV diagnostics market is projected to grow at a consistent CAGR of 7.9%.The market for HIV diagnostics is anticipated to grow during the projected period, from US$ 3.0 billion in 2022 to US$ 6.4 billion in 2032.

About Future Market Insights, Inc :

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

SOURCE: Future Market Insights, Inc.

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.